About: Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis
Creator	Singh, Meenu Kumar Bhadada, Sanjay Ravindra, Khaiwal Singh, Vivek Verma, Savita
Source	Medline; PMC
abstract	Globally, both obesity and underweight are severe health risks for various diseases. The current study systematically examined the emerging evidence to identify an association between body mass index (BMI) and COVID-19 disease outcome. Online literature databases (e.g., Google Scholar, PubMed, MEDLINE, EMBASE, Scopus, Medrixv and BioRixv) were screened following standard search strategy having the appropriate keyword such as “Obesity”, “Underweight”, “BMI”, “Body Mass Index”, “2019-nCov”, “COVID-19, “novel coronavirus”, “coronavirus disease”. Studies published till 20(th) April 2020 were included without language restriction. These studies include case reports, case series, cohort, and any other which reported BMI, overweight/obesity or underweight, and its complication with COVID-19 disease. This study observed COVID-19 infection among BMI < 25 kg/m(2) with prevalence of 0.60 (95%CI: 0.34–0.86, I(2) = − 76.77) as compared to the 0.34 (95%CI: 0.23–0.44, I(2) = 53.45% heterogeneity) having BMI > 25 kg/m(2). The results of the current study show that BMI plays a significant role in COVID-19 severity in all age groups, especially the older individuals. A panel of doctors and nursing staff should review COVID-19 patients with higher BMI with other co-morbidities (diabetes and hypertension), and they should be given increased vigilance, priority in testing, and treatment to control the associated co-morbidities. Further, the COVID-19 patients whose illness entered 7–10 days, age > 50 years, and elevated CRP levels should be given additional medical considerations. Our finding showed that the population and patients with high BMI have moderate to high risk of medical complications with COVID-19, and hence, their health status should be monitored more frequently including monitoring of blood pressure and blood glucose.
has issue date	2020-07-24(xsd:dateTime)
bibo:doi	10.1007/s11356-020-10132-4
bibo:pmid	32710359
has license	no-cc
sha1sum (hex)	031c61ffbe778d39ba8aa346e0a012eb5007fc75
schema:url	https://doi.org/10.1007/s11356-020-10132-4
resource representing a document's title	Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis
has PubMed Central identifier	PMC7380664
has PubMed identifier	32710359
schema:publication	Environ Sci Pollut Res Int
resource representing a document's body	covid:031c61ffbe778d39ba8aa346e0a012eb5007fc75#body_text
is schema:about of	named entity 'age' named entity 'entered' named entity 'BMI' named entity 'VARIOUS' named entity 'TO IDENTIFY' named entity 'HEALTH' named entity 'restriction' named entity 'BMI' named entity 'study' named entity 'levels' named entity 'This' named entity 'infection' named entity 'testing' named entity 'nursing' named entity 'overweight' named entity 'hypertension' named entity 'BMI' named entity 'risks' named entity 'underweight' named entity 'heterogeneity' named entity 'blood glucose' named entity 'CRP' named entity 'obesity' named entity 'case reports' named entity 'COVID-19' named entity 'co-morbidities' named entity 'medical complications' named entity 'body mass index' named entity 'risk factor' named entity 'metaanalysis' named entity 'underweight' named entity 'obese' named entity 'infection' named entity 'standard error' named entity 'COVID' named entity 'Google Scholar' named entity 'COVID-19' named entity 'influenza A virus' named entity 'COVID' named entity 'China' named entity 'COVID-19' named entity 'EMBASE' named entity 'random effects' named entity 'coronavirus infection' named entity 'adult respiratory distress syndrome' named entity 'BMI' named entity 'thromboembolic' named entity 'meta-analysis' named entity 'forest plot' named entity 'virus shedding' named entity 'BMI' named entity 'risk factors' named entity 'systematic review' named entity 'BMI' named entity 'confounders' named entity 'Underweight' named entity 'COVID' named entity 'obesity' named entity 'obesity' named entity 'pneumonia' named entity 'infection rate' named entity 'hypertension' named entity 'BMI' named entity 'malignancy' named entity 'obesity' named entity 'risk factor' named entity 'well-being' named entity 'BMI' named entity 'viral pathogenesis' named entity 'COVID-19' named entity 'mycobacterium tuberculosis' named entity 'South Korea' named entity 'coronavirus' named entity 'follow-up' named entity 'Italy' named entity 'diabetic patients' named entity 'noncommunicable diseases'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software